Safety analysis of antineoplastic drugs for lung cancer: a retrospective analysis based on Shaanxi Province in Western China-Reference-Cited by-同舟云学术

Safety analysis of antineoplastic drugs for lung cancer: a retrospective analysis based on Shaanxi Province in Western China

Published:2023-03-21 Issue: Volume: Page:1-7
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Lei Shuang¹²,Wang Ningsheng¹²,Ren Biqi¹²,Lin Shuzhi¹²,Feng Bianling¹²

Affiliation:

1. The Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an, Shaanxi, China

2. The Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an, Shaanxi, China

Funder

the National Social Science Foundation of China

Department of science and technology of Shaanxi Province

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2023.2193394

Reference35 articles.

1. International Agency for Research on Cancer (IARC) of the World Health Organization (WHO). The latest global cancer data for 2020. 2020. Available from: https://www.iarc.who.int/faq/latest-global-cancer-data-2020-qa/. [cited 2021 Nov 31]

2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

3. Assessment of medication adherence, medication safety awareness and medication practice among patients with lung cancer: A multicentre cross‐sectional study

4. The Patient’s Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety analysis of therapeutic drugs for breast cancer patients and construction of a predictive model for serious adverse drug reactions;European Journal of Clinical Pharmacology;2023-12-15